Synergia Medical Announces Strong Results for nao.vns First-in-Human Study
Synergia Medical’s NAO.VNS™ device, implanted in five patients in Belgium, has met its primary safety endpoint in the AURORA...
Allo-Inkt Combination Data in 2L Gastric Cancer at AACR
MiNK Therapeutics presented Phase 2 data at the AACR IO Annual Meeting showcasing the potential of its allogeneic iNKT...
Leronlimab Shows Promise in mTNBC Patient Survival
CytoDyn Inc. announced encouraging survival outcomes in a group of patients with metastatic triple-negative breast cancer (mTNBC) treated with...
Versamune® HPV Clinical Cancer Research Results
PDS Biotechnology Corporation announced positive clinical trial results for its lead immunotherapy candidate, Versamune® HPV, in the treatment of...
Calidi Starts High-Grade Glioma Trial Recruitment
Calidi Biotherapeutics has begun enrolling patients at Northwestern University/Northwestern Memorial Hospital for a clinical trial of CLD-101, an immunotherapy...
Brain Exercise Lowers Fatigue in MS Study
Researchers at New York University (NYU) found that brain exercises from the BrainHQ app, developed by Posit Science, reduced...
Leti-101 Shows Promise in Preclinical Huntington’s Disease Study
ElevateBio has unveiled preclinical data for LETI-101, a CRISPR-based therapy for Huntington’s Disease (HD) being developed by its subsidiary,...
FDA Grants Auron Therapeutics Fast Track Designation for AUTX-703 to Treat AML
Auron Therapeutics received FDA Fast Track designation for AUTX-703, an oral KAT2A/B degrader, for treating relapsed or refractory acute...
Preparing and Upskilling the Clinical Trial Workforce for AI Innovation
The 2025 SCOPE Summit’s fireside chat focused on how companies are preparing and upskilling their clinical trial workforce to...
Duvakitug Shows Promise in Ulcerative Colitis and Crohn’s Disease
Teva Pharmaceuticals and Sanofi announced positive Phase 2b results for duvakitug, a novel antibody targeting TL1A, in patients with...
